摘要
目的分析新型冠状病毒肺炎期间广东省某高校医院门诊药品新规定对门诊药品费用、门诊处方量的影响。方法选取广东外语外贸大学门诊部为研究对象。比较2018、2019、2020年1—5月门诊药品费用及2018、2019、2020年6—12月门诊药品费用。比较2018、2019、2020年1—5月门诊处方量。采用本院自制的门诊用药满意度调查量表,调查2020年1—12月对门诊药品管理的满意度。同时访谈10名患者,了解他们在新规后的用药情况。结果相较于2018、2019年1—5月门诊药品费用,2020年同期分别减少了166.31万元和180.01万元。从人员分类分析,教职工门诊药品费用减少的绝对值最大,分别为68.60万元和96.04万元。相较于2018、2019年6—12月门诊药品费用,2020年同期分别减少了24.52万元和8.80万元。相较于2018、2019年1—5月门诊处方量,2020年同期分别减少了17016和20319张。本次共发放500份调查问卷,回收有效问卷493份,有效问卷回收率为98.6%。其中,非常满意320人,满意165人,满意度为97%。10名患者均表示新规后,实际用药数量、金额变化不大。结论新的门诊药品处方管理规定可方便患者购药治病,安抚病人,提高患者治病顺应性。
Objective To investigate the effects of new regulations on outpatient drug costs and drug prescription in a university hospital in Guangdong Province during COVID-19.Methods Patients visited the outpatient department of Guangdong University of Foreign Studies was selected as the subjects.Outpatient drug costs from January to May in 2018,2019 and 2020 were compared with those from June to December in 2018,2019 and 2020.Outpatient prescriptions from January to May in 2018,2019,and 2020 were compared.The satisfaction with outpatient medication management from January to December in 2020 was investigated using our self-made outpatient medication satisfaction survey scale.A total of 10 patients were also interviewed to understand their medication use after the new regulation.Results Compared to the outpatient drug costs from January to May in 2018 and 2019,the costs decreased by 1663100 and 1800100 RMB during the same period in 2020,respectively.When analyzed by personnel category,faculty and staff outpatient drug costs decreased the most in absolute terms,by 686000 and 960400 RMB,respectively.Compared to the outpatient drug costs from June to December in 2018 and 2019,there was a decrease of 245200 and 88000 RMB during the same period in 2020,respectively.Compared to the outpatient prescriptions from January to May in 2018 and 2019,there were 17016 and 20319 fewer prescriptions during the same period in 2020,respectively.A total of 500 questionnaires were distributed and 493 valid questionnaires were collected,with a valid questionnaire recovery rate of 98.6%.Among the respondents,320 of them were very satisfied,165 were satisfied,with a satisfaction rate of 97%.All 10 patients indicated that the actual amount and costs of medication used did not change markedly after the new regulation.Conclusion The new regulations on outpatient drug prescription management can facilitate the purchase of medication for treatment,reassure patients,and improve their compliances with treatment.
作者
刘志林
李玲
陈晓容
彭丽雅
肖丹
Liu Zhilin;Li Ling;Chen Xiaorong;Peng Liya;Xiao Dan(Outpatient Department,Guangdong University of Foreign Studies,Guangzhou 510420,China)
出处
《保健医学研究与实践》
2022年第7期179-181,共3页
Health Medicine Research and Practice
关键词
新型冠状病毒
门诊药品
处方
管理
药费
COVID-19
Outpatient medication
Prescription
Management
Medication cost